FBXW5 inhibitors are a class of small molecules designed to inhibit the activity of FBXW5, a member of the F-box protein family, which is involved in the ubiquitin-proteasome system (UPS). FBXW5 functions as part of an E3 ubiquitin ligase complex known as SCF (Skp1-Cul1-F-box) that mediates the ubiquitination of specific protein substrates, targeting them for degradation. The F-box proteins are critical for substrate recognition in the SCF complex, and FBXW5 plays a specific role in regulating key proteins involved in cellular processes such as mitosis, cell cycle progression, and signal transduction. Inhibitors of FBXW5 are designed to block the interaction between FBXW5 and its substrates, thereby preventing the ubiquitination and subsequent degradation of these proteins.
By disrupting the activity of FBXW5, these inhibitors can lead to an accumulation of substrates that would otherwise be degraded, affecting various cellular pathways. FBXW5 inhibition can influence cellular dynamics by altering the balance of protein turnover, impacting processes like spindle assembly and centrosome duplication. This perturbation in protein homeostasis may lead to significant changes in the intracellular environment, with cascading effects on cell signaling, division, and growth. Research into FBXW5 inhibitors typically focuses on understanding their structural binding characteristics, mechanism of inhibition, and the broader biological consequences of modulating this specific F-box protein's activity within the context of cellular ubiquitin regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can prevent degradation of ubiquitinated proteins. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Another proteasome inhibitor, could prevent the degradation of ubiquitinated proteins. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibitor of NEDD8-activating enzyme, affecting the activity of cullin-RING ligases. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates the activity of E3 ubiquitin ligases, such as cereblon. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Analog of thalidomide, modulates the activity of cereblon. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Antagonist of MDM2, a ubiquitin ligase that targets p53 for degradation. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibitor of ubiquitin activating enzyme E1. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $77.00 $188.00 $431.00 | 1 | |
Broad-spectrum deubiquitinase inhibitor. | ||||||